Mediplantex National Pharmaceutical JSC (HNX:MED)

Market Cap	253.16B +55.0%
Revenue (ttm)	366.83B -17.2%
Net Income	15.83B +3.8%
EPS	1,275.86 +3.8%
Shares Out	12.41M
PE Ratio	15.99
Forward PE	n/a
Dividend	1,200.00 (5.88%)
Ex-Dividend Date	Jul 16, 2025

Volume	100
Average Volume	2,733
Open	20,400
Previous Close	n/a
Day's Range	20,400 - 20,400
52-Week Range	20,400 - 28,600
Beta	-0.01
RSI	35.61
Earnings Date	Apr 17, 2026

About HNX:MED

Mediplantex National Pharmaceutical Joint Stock Company produces and trades in pharmaceutical products in Vietnam. The company offers pharmaceutical products in various categories, including drugs from herbals; analgesics, corticosteroid, and anti-inflammatory drugs; antibiotics; cerebral circulation, heart, and lung drugs; anti-malarial, demostasis, gout, diabetes, allergies, and osteoarthritis drugs; acid amin, vitamins, and minerals; and other products. It also provides pharmaceutical chemicals and medicinal herbs; and extracting and semi sy...

• Industry: Pharmaceutical Preparations
• Founded: 2005
• Employees: 310
• Stock Exchange: Hanoi Stock Exchange
• Ticker Symbol: MED

Financial Performance

In 2025, HNX:MED's revenue was 366.83 billion, a decrease of -17.22% compared to the previous year's 443.14 billion. Earnings were 15.83 billion, an increase of 3.85%.